CVA Family Office »

Aurinia Pharmaceuticals shares owned by CVA Family Office

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by CVA Family Office from 13F filings

Historical chart of CVA Family Office investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by CVA Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by CVA Family Office

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2k 139 8.99

More positions owned by CVA Family Office

Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Fds Inf Tech Etf (VGT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Apple (AAPL)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Schwab Strategic Tr Schwb Fdt Emk Lg (FNDE)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)

View all positions for CVA Family Office

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals